Dr. Rahmo will be chairing the first day at the 7th Alcor Drug Discovery Platform (ADDP) in Princeton, NJ, on April 11th-12th, 2024.
He is a VIP speaker for an exclusive presentation on Small Mobile Stem Cells, the new paradigm in regenerative medicine. As one of the first targets of these unique cells, Dr. Rahmo will discuss their potential to alleviate the widespread chronic disease known as Chronic Obstructive Pulmonary Disease (COPD).
Join Dr. Rahmo by attending the panel discussion with Nikolaos Tezapsidis, CEO of Neurotez Inc., who will discuss how to catapult ourselves into the future of personalized medicine. Shahar Keinan, CEO of Polaris Quantum Biotech, who will discuss using QuADD (Quantum-Aided Drug Design) for faster, better, and more diverse leads. Randi Altschul, CEO of Pop Test Oncology/Palisades Therapeutics, will share insights on how a small entrepreneurial company can succeed in the pharmaceutical business.
Don't miss this opportunity to learn about the future of medicine from the leading experts in the field.
ADDP is designed to inspire international and interdisciplinary exchange at the forefront of drug research and to accelerate cooperation for new drug development. The Drug Discovery Platform will attract senior strategic decision-makers with top-level speakers, interactive round tables, knowledge-sharing panel sessions, in-depth workshops, and superb networking.
For more information, visit their LinkedIn page or contact us.
